It has been demonstrated that tumor-infiltrated MDSCs (compared to normal splenic myeloid cells) express higher levels of lipid transport proteins, induced by tumor-derived cytokines (G-CSF and GM-CSF) and through STAT3 and STAT5 signaling. The gene discussed is STAT3; the disease is neoplasm.